{
    "clinical_study": {
        "@rank": "107489", 
        "arm_group": [
            {
                "arm_group_label": "SSP-004184 (Child-Pugh A Liver Impaired)", 
                "arm_group_type": "Experimental", 
                "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis."
            }, 
            {
                "arm_group_label": "SSP-004184 (Child-Pugh B Liver Impaired)", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "SSP-004184 (Child-Pugh C Liver Impaired)", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "SSP-004184 (Matched Healthy Subjects)", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate how much of the study drug SSP-004184 (SPD602)  is\n      absorbed by the body and how long it takes to be eliminated from the body in healthy\n      subjects and subjects with mild, moderate, and severe hepatic (liver) impairment compared\n      with subjects with healthy normal liver function."
        }, 
        "brief_title": "Study of SSP-004184 (SPD602) in Healthy Adults and Subjects With Impaired Liver Function", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "All subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                            "title": "Hepatic Impairment"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "All subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                            "title": "Matched Healthy Subjects"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "23"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "20"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "43"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "5.13", 
                                                "@value": "56.3"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "5.51", 
                                                "@value": "55.1"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "5.28", 
                                                "@value": "55.7"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "Years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "1"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "1"
                                                }
                                            ]
                                        }, 
                                        "sub_title": ">=65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "22"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "20"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "42"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age, Customized", 
                            "units": "Participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "4"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "4"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "8"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "19"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "16"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "35"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "Participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "23"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "20"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "43"
                                            }
                                        ]
                                    }, 
                                    "sub_title": "UNITED STATES"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "Participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "If a multicenter publication is not submitted within twelve (12) months after conclusion, abandonment or termination of the Study at all sites, or after Sponsor confirms there shall be no multicenter Study publication, the Institution and/or such Principal Investigator may publish the results from the Institution site individually."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "AUC can be used as a measure of drug exposure. It is derived from drug concentration and time so it gives a measure how much and how long a drug stays in a body.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh A Liver Impaired) 50 mg/kg"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh B Liver Impaired) 45 mg/kg"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh B Liver Impaired) 50 mg/kg"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh C Liver Impaired) 45 mg/kg"
                                }, 
                                {
                                    "@group_id": "O5", 
                                    "description": "All subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Matched Healthy Subjects) 45 mg/kg"
                                }, 
                                {
                                    "@group_id": "O6", 
                                    "description": "All subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Matched Healthy Subjects) 50 mg/kg"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "8"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "5"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "3"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "7"
                                                    }, 
                                                    {
                                                        "@group_id": "O5", 
                                                        "@value": "10"
                                                    }, 
                                                    {
                                                        "@group_id": "O6", 
                                                        "@value": "10"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "57645.3", 
                                                        "@value": "254327.7"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "157352.1", 
                                                        "@value": "443053.5"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "149123.5", 
                                                        "@value": "288579.6"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@spread": "111201.8", 
                                                        "@value": "410414.3"
                                                    }, 
                                                    {
                                                        "@group_id": "O5", 
                                                        "@spread": "83155.2", 
                                                        "@value": "209989.8"
                                                    }, 
                                                    {
                                                        "@group_id": "O6", 
                                                        "@spread": "112004.9", 
                                                        "@value": "310281.3"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "AUC can be used as a measure of drug exposure. It is derived from drug concentration and time so it gives a measure how much and how long a drug stays in a body.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Area Under the Plasma Concentration-time Curve (AUC) of SSP-004184", 
                                    "units": "ng*h/ml"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic Analysis Set consists of all subjects in the Safety Analysis Set for whom the primary pharmacokinetic data were considered sufficient and interpretable.  Safety Analysis Set consists of all enrolled subjects who took at least 1 dose of investigational product and had at least 1 post-dose safety assessment.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 96 hours post-dose", 
                        "title": "Area Under the Plasma Concentration-time Curve (AUC) of SSP-004184", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Cmax is a term that refers to the maximum (or peak) concentration that a drug achieves in the body after the drug has been administrated.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh A Liver Impaired) 50 mg/kg"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh B Liver Impaired) 45 mg/kg"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh B Liver Impaired) 50 mg/kg"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh C Liver Impaired) 45 mg/kg"
                                }, 
                                {
                                    "@group_id": "O5", 
                                    "description": "All subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Matched Healthy Subjects) 45 mg/kg"
                                }, 
                                {
                                    "@group_id": "O6", 
                                    "description": "All subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Matched Healthy Subjects) 50 mg/kg"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "8"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "5"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "3"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "7"
                                                    }, 
                                                    {
                                                        "@group_id": "O5", 
                                                        "@value": "10"
                                                    }, 
                                                    {
                                                        "@group_id": "O6", 
                                                        "@value": "10"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "29689.1", 
                                                        "@value": "98887.5"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "28777.7", 
                                                        "@value": "121460.0"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "52920.5", 
                                                        "@value": "109166.7"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@spread": "34807.1", 
                                                        "@value": "123985.0"
                                                    }, 
                                                    {
                                                        "@group_id": "O5", 
                                                        "@spread": "28538.1", 
                                                        "@value": "83350.0"
                                                    }, 
                                                    {
                                                        "@group_id": "O6", 
                                                        "@spread": "41016.6", 
                                                        "@value": "108890.0"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Cmax is a term that refers to the maximum (or peak) concentration that a drug achieves in the body after the drug has been administrated.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Maximum Plasma Concentration (Cmax) of SSP-004184", 
                                    "units": "ng/ml"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic Analysis Set consists of all subjects in the Safety Analysis Set for whom the primary pharmacokinetic data were considered sufficient and interpretable.  Safety Analysis Set consists of all enrolled subjects who took at least 1 dose of investigational product and had at least 1 post-dose safety assessment.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 96 hours post-dose", 
                        "title": "Maximum Plasma Concentration (Cmax) of SSP-004184", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Tmax is the time after administration of a drug when the maximum plasma concentration in the body is reached.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh A Liver Impaired) 50 mg/kg"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh B Liver Impaired) 45 mg/kg"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh B Liver Impaired) 50 mg/kg"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh C Liver Impaired) 45 mg/kg"
                                }, 
                                {
                                    "@group_id": "O5", 
                                    "description": "All subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Matched Healthy Subjects) 45 mg/kg"
                                }, 
                                {
                                    "@group_id": "O6", 
                                    "description": "All subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Matched Healthy Subjects) 50 mg/kg"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "8"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "5"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "3"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "7"
                                                    }, 
                                                    {
                                                        "@group_id": "O5", 
                                                        "@value": "10"
                                                    }, 
                                                    {
                                                        "@group_id": "O6", 
                                                        "@value": "10"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@lower_limit": "1.0", 
                                                        "@upper_limit": "1.5", 
                                                        "@value": "1.3"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@lower_limit": "1.0", 
                                                        "@upper_limit": "2.5", 
                                                        "@value": "1.5"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@lower_limit": "1.0", 
                                                        "@upper_limit": "1.5", 
                                                        "@value": "1.5"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@lower_limit": "1.0", 
                                                        "@upper_limit": "2.5", 
                                                        "@value": "1.5"
                                                    }, 
                                                    {
                                                        "@group_id": "O5", 
                                                        "@lower_limit": "1.0", 
                                                        "@upper_limit": "1.5", 
                                                        "@value": "1.0"
                                                    }, 
                                                    {
                                                        "@group_id": "O6", 
                                                        "@lower_limit": "1.0", 
                                                        "@upper_limit": "2.0", 
                                                        "@value": "1.0"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Tmax is the time after administration of a drug when the maximum plasma concentration in the body is reached.", 
                                    "dispersion": "Full Range", 
                                    "param": "Median", 
                                    "title": "Time of Maximum Plasma Concentration (Tmax) for SSP-004184", 
                                    "units": "hours"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic Analysis Set consists of all subjects in the Safety Analysis Set for whom the primary pharmacokinetic data were considered sufficient and interpretable.  Safety Analysis Set consists of all enrolled subjects who took at least 1 dose of investigational product and had at least 1 post-dose safety assessment.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 96 hours post-dose", 
                        "title": "Time of Maximum Plasma Concentration (Tmax) for SSP-004184", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "The time it takes for the blood plasma concentration of a substance to halve.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh A Liver Impaired) 50 mg/kg"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh B Liver Impaired) 45 mg/kg"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh B Liver Impaired) 50 mg/kg"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh C Liver Impaired) 45 mg/kg"
                                }, 
                                {
                                    "@group_id": "O5", 
                                    "description": "All subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Matched Healthy Subjects) 45 mg/kg"
                                }, 
                                {
                                    "@group_id": "O6", 
                                    "description": "All subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Matched Healthy Subjects) 50 mg/kg"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "8"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "5"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "3"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "7"
                                                    }, 
                                                    {
                                                        "@group_id": "O5", 
                                                        "@value": "10"
                                                    }, 
                                                    {
                                                        "@group_id": "O6", 
                                                        "@value": "10"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "17.54", 
                                                        "@value": "21.91"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "6.47", 
                                                        "@value": "11.37"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "0.94", 
                                                        "@value": "6.93"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@spread": "3.97", 
                                                        "@value": "6.79"
                                                    }, 
                                                    {
                                                        "@group_id": "O5", 
                                                        "@spread": "4.51", 
                                                        "@value": "12.51"
                                                    }, 
                                                    {
                                                        "@group_id": "O6", 
                                                        "@spread": "8.62", 
                                                        "@value": "16.19"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "The time it takes for the blood plasma concentration of a substance to halve.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Plasma Half-Life (T 1/2) of SSP-004184", 
                                    "units": "hours"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic Analysis Set consists of all subjects in the Safety Analysis Set for whom the primary pharmacokinetic data were considered sufficient and interpretable.  Safety Analysis Set consists of all enrolled subjects who took at least 1 dose of investigational product and had at least 1 post-dose safety assessment.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 96 hours post-dose", 
                        "title": "Plasma Half-Life (T 1/2) of SSP-004184", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "The rate at which a drug is removed from the body.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh A Liver Impaired) 50 mg/kg"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh B Liver Impaired) 45 mg/kg"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh B Liver Impaired) 50 mg/kg"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh C Liver Impaired) 45 mg/kg"
                                }, 
                                {
                                    "@group_id": "O5", 
                                    "description": "All subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Matched Healthy Subjects) 45 mg/kg"
                                }, 
                                {
                                    "@group_id": "O6", 
                                    "description": "All subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Matched Healthy Subjects) 50 mg/kg"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "8"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "5"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "3"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "7"
                                                    }, 
                                                    {
                                                        "@group_id": "O5", 
                                                        "@value": "10"
                                                    }, 
                                                    {
                                                        "@group_id": "O6", 
                                                        "@value": "10"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "0.042", 
                                                        "@value": "0.204"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "0.035", 
                                                        "@value": "0.110"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "0.099", 
                                                        "@value": "0.198"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@spread": "0.047", 
                                                        "@value": "0.119"
                                                    }, 
                                                    {
                                                        "@group_id": "O5", 
                                                        "@spread": "0.097", 
                                                        "@value": "0.246"
                                                    }, 
                                                    {
                                                        "@group_id": "O6", 
                                                        "@spread": "0.072", 
                                                        "@value": "0.182"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "The rate at which a drug is removed from the body.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Total Body Clearance (CL/F) of SSP-004184", 
                                    "units": "L/h/kg"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic Analysis Set consists of all subjects in the Safety Analysis Set for whom the primary pharmacokinetic data were considered sufficient and interpretable.  Safety Analysis Set consists of all enrolled subjects who took at least 1 dose of investigational product and had at least 1 post-dose safety assessment.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 96 hours post-dose", 
                        "title": "Total Body Clearance (CL/F) of SSP-004184", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "The distribution of a medication between plasma and the rest of the body.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh A Liver Impaired) 50 mg/kg"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh B Liver Impaired) 45 mg/kg"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh B Liver Impaired) 50 mg/kg"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "The Child-Pugh Score is a scoring system used to determine the prognosis with cirrhosis and need for liver transplantation. Scoring is based upon albumin, ascites, total bilirubin, prothrombin time, and encephalopathy. Each category is based on a scoring system of 1-3 with 3 being the worst and a total score range of 5-15.  It is broken into categories A (score of 5-6), B (score of 7-9), and C (score of 10-15) with worsening from A to C for prognosis.\nAll subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Child-Pugh C Liver Impaired) 45 mg/kg"
                                }, 
                                {
                                    "@group_id": "O5", 
                                    "description": "All subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Matched Healthy Subjects) 45 mg/kg"
                                }, 
                                {
                                    "@group_id": "O6", 
                                    "description": "All subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                                    "title": "SSP-004184 (Matched Healthy Subjects) 50 mg/kg"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "8"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "5"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "3"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "7"
                                                    }, 
                                                    {
                                                        "@group_id": "O5", 
                                                        "@value": "10"
                                                    }, 
                                                    {
                                                        "@group_id": "O6", 
                                                        "@value": "10"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "5.276", 
                                                        "@value": "6.344"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "1.210", 
                                                        "@value": "1.796"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "1.259", 
                                                        "@value": "2.043"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@spread": "1.539", 
                                                        "@value": "1.370"
                                                    }, 
                                                    {
                                                        "@group_id": "O5", 
                                                        "@spread": "1.420", 
                                                        "@value": "4.103"
                                                    }, 
                                                    {
                                                        "@group_id": "O6", 
                                                        "@spread": "2.237", 
                                                        "@value": "4.086"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "The distribution of a medication between plasma and the rest of the body.", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Volume of Distribution (Vz/F) of SSP-004184", 
                                    "units": "L/kg"
                                }
                            ]
                        }, 
                        "population": "Pharmacokinetic Analysis Set consists of all subjects in the Safety Analysis Set for whom the primary pharmacokinetic data were considered sufficient and interpretable.  Safety Analysis Set consists of all enrolled subjects who took at least 1 dose of investigational product and had at least 1 post-dose safety assessment.", 
                        "safety_issue": "No", 
                        "time_frame": "Over 96 hours post-dose", 
                        "title": "Volume of Distribution (Vz/F) of SSP-004184", 
                        "type": "Primary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "All subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                            "title": "Hepatic Impairment"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "All subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1 (or a revised dose if dose modifications are warranted).", 
                            "title": "Matched Healthy Subjects"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "23", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "20", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "23", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "20", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "pre_assignment_details": "One subject withdrew from study prior to randomization (n = 43)."
            }, 
            "point_of_contact": {
                "name_or_title": "Study Physician", 
                "organization": "Shire Development LLC", 
                "phone": "+1 866 842 5335"
            }, 
            "reported_events": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "title": "Hepatic Impairment"
                        }, 
                        {
                            "@group_id": "E2", 
                            "title": "Matched Healthy Subjects"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "12", 
                                                "@subjects_at_risk": "23"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "17", 
                                                "@subjects_at_risk": "20"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "1", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "23"
                                            }, 
                                            {
                                                "@events": "1", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "20"
                                            }
                                        ], 
                                        "sub_title": "Constipation"
                                    }
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "0", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "23"
                                            }, 
                                            {
                                                "@events": "1", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "20"
                                            }
                                        ], 
                                        "sub_title": "Fatigue"
                                    }
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "0", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "23"
                                            }, 
                                            {
                                                "@events": "1", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "20"
                                            }
                                        ], 
                                        "sub_title": "Nasopharyngitis"
                                    }
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "2", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "23"
                                            }, 
                                            {
                                                "@events": "4", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "20"
                                            }
                                        ], 
                                        "sub_title": "Headache"
                                    }
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "0", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "23"
                                            }, 
                                            {
                                                "@events": "1", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "1", 
                                                "@subjects_at_risk": "20"
                                            }
                                        ], 
                                        "sub_title": "Anxiety"
                                    }
                                }, 
                                "title": "Psychiatric disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "10", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "10", 
                                                "@subjects_at_risk": "23"
                                            }, 
                                            {
                                                "@events": "17", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "17", 
                                                "@subjects_at_risk": "20"
                                            }
                                        ], 
                                        "sub_title": "Chromaturia"
                                    }
                                }, 
                                "title": "Renal and urinary disorders"
                            }
                        ]
                    }, 
                    "frequency_threshold": "5"
                }
            }
        }, 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Hepatic Impairment", 
            "Healthy"
        ], 
        "condition_browse": {
            "mesh_term": "Liver Diseases"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 18-65 years inclusive at the time of consent.\n\n          -  Willingness to comply with any applicable contraceptive requirements of the protocol\n             and is:\n\n          -  Male, or\n\n          -  Non pregnant, non lactating female\n\n          -  Females must be at least 90 days post partum or nulliparous.\n\n        Subjects who do not have hepatic impairment (healthy subjects)\n\n          -  Normal renal function.\n\n        Subjects with hepatic impairment\n\n          -  Subjects must provide a letter of evaluation from a hepatologist or copy of\n             supporting documents confirming the subject's hepatic impairment (a liver biopsy is\n             preferable but not mandatory).\n\n          -  Hepatic impairment should be primary and must not be a complication of an underlying\n             primary systemic disease (eg, patients with metastatic cancer and cancer cachexia)\n\n          -  Documented chronic stable liver impairment\n\n        Exclusion Criteria\n\n        Subjects who do not have hepatic impairment (healthy subjects)\n\n          -  A positive HIV antibody screen, Hepatitis B surface antigen, or Hepatitis C virus\n             antibody screen.\n\n        Subjects with hepatic impairment\n\n          -  Presence of a hepatocellular carcinoma, or an acute hepatic disease caused by an\n             infection or drug toxicity.\n\n          -  Presence of surgically created or transjugular intrahepatic portal systemic shunts.\n\n          -  A positive HIV antibody screen.\n\n          -  Renal insufficiency.\n\n        All subjects\n\n          -  Subject has a history of thyroid disorder.\n\n          -  History of nephrotic syndrome.\n\n          -  History of alcohol or other substance abuse within the last year.\n\n          -  A positive screen for alcohol or drugs of abuse.\n\n          -  Male subjects who consume more than 3 units of alcohol per day.  Female subjects who\n             consume more than 2 units of alcohol per day.  (1 alcohol unit = 1 beer [12 oz/355\n             mL] = 1 wine [5 oz/150 mL] = 1 liquor [1.5 oz/40 mL] = 0.75 oz/20 mL alcohol.)\n\n          -  Caffeine consumption: For healthy subjects: Routine consumption of more than 2 units\n             of caffeine per day or subjects who experience caffeine withdrawal headaches or have\n             a history of caffeine withdrawal headaches.  (One caffeine unit is contained in the\n             following items:  one 6 oz/180 mL cup of coffee, two 12 oz/355 mL (ie, 24 oz/710 mL\n             cola) cans of cola, one 12 oz/355 mL cup of tea, three 1 oz/28 g chocolate bars (ie,\n             3 oz/85 g chocolate).  Decaffeinated coffee, tea, or cola are not considered to\n             contain caffeine.)\n\n          -  Donation of blood or blood products within 60 days.\n\n          -  Substantial changes in eating habits within 30 days."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "44", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 19, 2012", 
        "firstreceived_results_date": "April 16, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01732263", 
            "org_study_id": "SPD602-105"
        }, 
        "intervention": {
            "arm_group_label": [
                "SSP-004184 (Child-Pugh A Liver Impaired)", 
                "SSP-004184 (Child-Pugh B Liver Impaired)", 
                "SSP-004184 (Child-Pugh C Liver Impaired)", 
                "SSP-004184 (Matched Healthy Subjects)"
            ], 
            "description": "All subjects will take a single oral dose of SSP-004184 (SPD602) (50 mg/kg) on Day 1", 
            "intervention_name": "SSP-004184", 
            "intervention_type": "Drug", 
            "other_name": "SPD602, FBS0701"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "April 16, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33014"
                    }, 
                    "name": "Clinical Pharmacology of Miami"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32809"
                    }, 
                    "name": "Orlando Clinical Research Center (OCRC)"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Phase 1, Open-label, Single-dose Study of the Pharmacokinetics, Safety, and Tolerability of SSP-004184 (SPD602) in Subjects With Hepatic Impairment Compared to Matched Healthy Subjects", 
        "overall_official": {
            "affiliation": "Clinical Pharmacology of Miami", 
            "last_name": "Kenneth Lasseter, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "AUC can be used as a measure of drug exposure. It is derived from drug concentration and time so it gives a measure how much and how long a drug stays in a body.", 
                "measure": "Area Under the Plasma Concentration-time Curve (AUC) of SSP-004184", 
                "safety_issue": "No", 
                "time_frame": "Over 96 hours post-dose"
            }, 
            {
                "description": "Cmax is a term that refers to the maximum (or peak) concentration that a drug achieves in the body after the drug has been administrated.", 
                "measure": "Maximum Plasma Concentration (Cmax) of SSP-004184", 
                "safety_issue": "No", 
                "time_frame": "Over 96 hours post-dose"
            }, 
            {
                "description": "Tmax is the time after administration of a drug when the maximum plasma concentration in the body is reached.", 
                "measure": "Time of Maximum Plasma Concentration (Tmax) for SSP-004184", 
                "safety_issue": "No", 
                "time_frame": "Over 96 hours post-dose"
            }, 
            {
                "description": "The time it takes for the blood plasma concentration of a substance to halve.", 
                "measure": "Plasma Half-Life (T 1/2) of SSP-004184", 
                "safety_issue": "No", 
                "time_frame": "Over 96 hours post-dose"
            }, 
            {
                "description": "The rate at which a drug is removed from the body.", 
                "measure": "Total Body Clearance (CL/F) of SSP-004184", 
                "safety_issue": "No", 
                "time_frame": "Over 96 hours post-dose"
            }, 
            {
                "description": "The distribution of a medication between plasma and the rest of the body.", 
                "measure": "Volume of Distribution (Vz/F) of SSP-004184", 
                "safety_issue": "No", 
                "time_frame": "Over 96 hours post-dose"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01732263"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Shire", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shire", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}